Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$4.22 +10.5%	$3.59	$2.34 ▼ $8.79	$152.17M	N/A	205,045 shs	100,485 shs
MBOT Microbot Medical	$3.86 +8.3%	$2.69	$0.82 ▼ $3.94	$175.14M	1.15	3.07 million shs	3.71 million shs
POCI Precision Optics	$4.80 +3.5%	$4.74	$3.47 ▼ $6.59	$36.82M	0.3	15,009 shs	850 shs
PROF Profound Medical	$4.73 +2.8%	$5.77	$3.89 ▼ $9.38	$144.39M	0.52	79,565 shs	47,491 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	+7.30%	-2.55%	+20.50%	+4.95%	+381,999,900.00%
MBOT Microbot Medical	+7.55%	+13.74%	+40.71%	+33.83%	+242.31%
POCI Precision Optics	-2.32%	-1.90%	-3.33%	+4.88%	-11.45%
PROF Profound Medical	-0.86%	-16.97%	-21.64%	-10.33%	-51.58%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	1.8782 of 5 stars	3.5	1.0	0.0	0.0	3.0	0.0	0.6
POCI Precision Optics	0.108 of 5 stars	0.0	3.0	0.0	0.0	0.0	0.8	0.0
PROF Profound Medical	1.7603 of 5 stars	3.5	1.0	0.0	0.0	1.7	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	3.00	Buy	$16.50	291.00% Upside
MBOT Microbot Medical	3.00	Buy	$9.00	133.46% Upside
POCI Precision Optics	0.00	N/A	N/A	N/A
PROF Profound Medical	3.00	Buy	$11.00	132.56% Upside

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$2.70M	56.36	N/A	N/A	$0.67 per share	6.30
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A
POCI Precision Optics	$19.10M	1.93	N/A	N/A	$1.66 per share	2.89
PROF Profound Medical	$10.68M	13.31	N/A	N/A	$1.31 per share	3.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	-$76.29M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	11/10/2025 (Estimated)
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	N/A
POCI Precision Optics	-$2.95M	-$0.89	N/A	∞	N/A	-32.84%	-54.03%	-32.48%	9/29/2025 (Estimated)
PROF Profound Medical	-$27.82M	-$1.46	N/A	N/A	N/A	-343.97%	-89.74%	-73.06%	11/6/2025 (Estimated)

Latest POCI, MBOT, PROF, and AVR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	PROF Profound Medical	-$0.43	-$0.52	-$0.09	-$0.52	$4.75 million	$2.21 million
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A
8/11/2025	Q2 2025 TU	AVR Anteris Technologies Global	-$0.5333	-$0.58	-$0.0467	-$0.58	$0.58 million	$0.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
POCI Precision Optics	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	2.41	2.38
MBOT Microbot Medical	N/A	12.06	12.06
POCI Precision Optics	0.11	1.99	1.26
PROF Profound Medical	0.11	8.53	10.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
MBOT Microbot Medical	16.30%
POCI Precision Optics	13.71%
PROF Profound Medical	47.86%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	N/A
MBOT Microbot Medical	4.74%
POCI Precision Optics	12.99%
PROF Profound Medical	1.52%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	138	36.06 million	N/A	N/A
MBOT Microbot Medical	20	45.55 million	43.39 million	Optionable
POCI Precision Optics	80	7.67 million	6.67 million	Not Optionable
PROF Profound Medical	150	30.05 million	29.60 million	Optionable

POCI, MBOT, PROF, and AVR Headlines

Recent News About These Companies

Profound Medical is a buy, Leede says

August 20 at 2:38 AM | cantechletter.comC

Profound Medical (NASDAQ:PROF) Issues Quarterly Earnings Results, Misses Expectations By $0.09 EPS

August 18, 2025 | marketbeat.com

Profound Medical: Smokes Is Everywhere, Initiate At Sell

August 18, 2025 | seekingalpha.com

Timelo Investment Management Inc. Raises Stock Position in Profound Medical (NASDAQ:PROF)

August 18, 2025 | marketbeat.com

Profound Medical Second Quarter 2025 Earnings: Misses Expectations

August 16, 2025 | finance.yahoo.com

Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript

August 16, 2025 | msn.com

Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...

August 15, 2025 | gurufocus.com

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

August 15, 2025 | msn.com

Q2 2025 Profound Medical Corp Earnings Call Transcript

August 14, 2025 | gurufocus.com

Profound Medical (PROF) Aims for 75% Revenue Growth Despite Q2 Loss

August 14, 2025 | gurufocus.com

Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates

August 14, 2025 | zacks.com

Profound Medical Reports Q2 2025 Growth and New Innovations in Prostate Treatment

August 14, 2025 | tipranks.com

Profound Medical Announces Second Quarter 2025 Financial Results

August 14, 2025 | financialpost.comF

Profound Medical Announces Second Quarter 2025 Financial Results

August 14, 2025 | globenewswire.com

Altium Capital Management LLC Sells 124,411 Shares of Profound Medical (NASDAQ:PROF)

August 14, 2025 | marketbeat.com

Profound Medical (PROF) Projected to Post Earnings on Thursday

August 7, 2025 | marketbeat.com

Profound Medical to Announce Q2 2025 Financial Results

July 24, 2025 | tipranks.com

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

July 24, 2025 | financialpost.comF

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

July 24, 2025 | globenewswire.com

'Profound Sadness': Colleagues, Friends Mourn Beloved East End Doctor Who Died During Triathlon

July 17, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

POCI, MBOT, PROF, and AVR Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$4.22 +0.40 (+10.47%)

As of 03:14 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Microbot Medical NASDAQ:MBOT

$3.86 +0.30 (+8.29%)

As of 03:35 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Precision Optics NASDAQ:POCI

$4.80 +0.16 (+3.47%)

As of 03:15 PM Eastern

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Profound Medical NASDAQ:PROF

$4.73 +0.13 (+2.83%)

As of 03:34 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time